Nuclear Dishevelled targets gene regulatory regions and promotes tumor growth.


Journal

EMBO reports
ISSN: 1469-3178
Titre abrégé: EMBO Rep
Pays: England
ID NLM: 100963049

Informations de publication

Date de publication:
04 06 2021
Historique:
revised: 03 03 2021
received: 07 04 2020
accepted: 11 03 2021
pubmed: 17 4 2021
medline: 29 6 2021
entrez: 16 4 2021
Statut: ppublish

Résumé

Dishevelled (DVL) critically regulates Wnt signaling and contributes to a wide spectrum of diseases and is important in normal and pathophysiological settings. However, how it mediates diverse cellular functions remains poorly understood. Recent discoveries have revealed that constitutive Wnt pathway activation contributes to breast cancer malignancy, but the mechanisms by which this occurs are unknown and very few studies have examined the nuclear role of DVL. Here, we have performed DVL3 ChIP-seq analyses and identify novel target genes bound by DVL3. We show that DVL3 depletion alters KMT2D binding to novel targets and changes their epigenetic marks and mRNA levels. We further demonstrate that DVL3 inhibition leads to decreased tumor growth in two different breast cancer models in vivo. Our data uncover new DVL3 functions through its regulation of multiple genes involved in developmental biology, antigen presentation, metabolism, chromatin remodeling, and tumorigenesis. Overall, our study provides unique insight into the function of nuclear DVL, which helps to define its role in mediating aberrant Wnt signaling.

Identifiants

pubmed: 33860601
doi: 10.15252/embr.202050600
pmc: PMC8183407
doi:

Substances chimiques

Dishevelled Proteins 0
Phosphoproteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e50600

Subventions

Organisme : NIH HHS
ID : S10 OD025115
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA044999
Pays : United States
Organisme : Cancer Prevention and Research Institute of Texas (CPRIT)
ID : RR140008
Organisme : NCI NIH HHS
ID : R01 CA155223
Pays : United States
Organisme : HHS | NIH | National Institute on Drug Abuse (NIDA)
ID : DA 044999-01A1

Informations de copyright

© 2021 The Authors.

Références

Curr Top Dev Biol. 2016;117:75-91
pubmed: 26969973
Nucleic Acids Res. 2013 Dec;41(22):10032-43
pubmed: 24038352
Dev Cell. 2017 Nov 20;43(4):436-448.e6
pubmed: 29103953
Clin Epigenetics. 2019 Mar 12;11(1):48
pubmed: 30867030
Dev Cell. 2010 Apr 20;18(4):579-91
pubmed: 20412773
Cell. 2007 Nov 16;131(4):633-6
pubmed: 18022353
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):391-6
pubmed: 24371308
Exp Mol Med. 2017 Apr 28;49(4):e324
pubmed: 28450737
Front Cell Dev Biol. 2020 Nov 19;8:589016
pubmed: 33330467
Nat Med. 2018 Mar;24(3):262-270
pubmed: 29431745
PLoS One. 2014 Jun 04;9(6):e98861
pubmed: 24897117
Acta Biochim Biophys Sin (Shanghai). 2013 Feb;45(2):71-9
pubmed: 23027379
Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10747-52
pubmed: 16815967
Oncogene. 2009 May 28;28(21):2163-72
pubmed: 19377513
J Biol Chem. 2002 Oct 11;277(41):38239-44
pubmed: 12154096
J Mol Cell Cardiol. 2009 Mar;46(3):370-7
pubmed: 19109969
Int J Mol Sci. 2020 Oct 28;21(21):
pubmed: 33126517
Carcinogenesis. 2011 Mar;32(3):434-42
pubmed: 21173432
Mol Cancer. 2010 Dec 21;9:318
pubmed: 21176152
Nat Commun. 2019 Jun 6;10(1):2481
pubmed: 31171792
Dev Cell. 2015 Mar 23;32(6):707-18
pubmed: 25805136
Genome Biol. 2011 Aug 22;12(8):R83
pubmed: 21859476
Genes Dev. 2019 Sep 1;33(17-18):1117-1135
pubmed: 31481536
EMBO J. 2012 Mar 7;31(5):1109-22
pubmed: 22234184
BMC Genomics. 2008 Oct 16;9:488
pubmed: 18925949
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21931-6
pubmed: 21106759
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3121-3126
pubmed: 28270600
J Cell Biol. 2000 Jun 26;149(7):1433-42
pubmed: 10871283
PLoS Genet. 2016 Aug 08;12(8):e1006217
pubmed: 27500936
Prog Mol Biol Transl Sci. 2016;144:3-47
pubmed: 27865461
J Biol. 2005;4(1):3
pubmed: 15720724
Exp Mol Pathol. 2010 Oct;89(2):140-8
pubmed: 20471975
J Mol Biol. 2011 May 27;409(1):36-46
pubmed: 21272588
Cancer Res. 2014 Feb 1;74(3):775-86
pubmed: 24247718
EMBO J. 2018 Dec 3;37(23):
pubmed: 30373810
Immunogenetics. 2019 Mar;71(3):161-170
pubmed: 30215098
Genes Cancer. 2015 Sep;6(9-10):408-21
pubmed: 26622943
Mol Med Rep. 2017 Feb;15(2):899-907
pubmed: 28035400
Mol Cancer Res. 2018 Oct;16(10):1530-1542
pubmed: 29921733
Am J Pathol. 1999 Feb;154(2):515-23
pubmed: 10027409
J Clin Invest. 2020 Sep 1;130(9):4637-4651
pubmed: 32484803
Nat Commun. 2018 Jun 12;9(1):2301
pubmed: 29895829
Oncol Rep. 2006 Mar;15(3):701-7
pubmed: 16465433
Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):14867-72
pubmed: 18806226
J Biol. 2005;4(1):1
pubmed: 15720722
Front Oncol. 2020 Dec 10;10:576362
pubmed: 33363010
Development. 2016 Mar 1;143(5):810-21
pubmed: 26932671
Epigenomics. 2015;7(3):503-19
pubmed: 26077434
Nat Biotechnol. 2020 Jun;38(6):675-678
pubmed: 32444850
Science. 2014 Oct 3;346(6205):1248012
pubmed: 25278615
Gene. 2017 Sep 5;627:337-342
pubmed: 28669924
Nat Rev Cancer. 2015 Jun;15(6):334-46
pubmed: 25998713
Nucleic Acids Res. 2018 Jan 4;46(D1):D794-D801
pubmed: 29126249
Mol Cells. 2017 Mar;40(3):169-177
pubmed: 28359147
PLoS Genet. 2006 Mar;2(3):e40
pubmed: 16596166
Sci Signal. 2017 Jan 10;10(461):
pubmed: 28074006
Immunity. 2007 Feb;26(2):227-39
pubmed: 17306568
Cancer Cell. 2004 Nov;6(5):497-506
pubmed: 15542433
Nat Rev Genet. 2014 Apr;15(4):272-86
pubmed: 24614317
Mol Cell. 2018 Jun 7;70(5):825-841.e6
pubmed: 29861161
BMC Bioinformatics. 2017 Mar 2;18(1):142
pubmed: 28249561
Sci Rep. 2019 Nov 7;9(1):16257
pubmed: 31700102
Nucleic Acids Res. 2020 Jan 8;48(D1):D498-D503
pubmed: 31691815
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Nat Commun. 2019 Oct 8;10(1):4562
pubmed: 31594934
Mod Pathol. 2011 Feb;24(2):209-31
pubmed: 21076461
PLoS Genet. 2008 Nov;4(11):e1000259
pubmed: 19008950
Breast Cancer Res. 2007;9(5):R63
pubmed: 17897439
Am J Pathol. 2010 Jun;176(6):2911-20
pubmed: 20395444
Oncogene. 2008 Feb 28;27(10):1478-88
pubmed: 17724465
Cancer Invest. 2010 Jul;28(6):672-8
pubmed: 20394500
Cell Mol Immunol. 2020 Sep;17(9):925-939
pubmed: 32699351
Cell. 2007 May 18;129(4):823-37
pubmed: 17512414
Oncogene. 2019 May;38(21):4047-4060
pubmed: 30705400
Nucleic Acids Res. 2018 Feb 16;46(3):1180-1195
pubmed: 29186616
Oncotarget. 2016 Feb 2;7(5):5094-109
pubmed: 26783963
Genes Dev. 2018 Jan 15;32(2):181-193
pubmed: 29440247
Cancer Res. 2009 Jul 1;69(13):5364-73
pubmed: 19549913
J Genet Genomics. 2018 Dec 20;45(12):639-650
pubmed: 30594465
Cell Death Dis. 2016 May 26;7:e2236
pubmed: 27228351
Oncogene. 2020 Mar;39(11):2258-2274
pubmed: 31831834
Ann N Y Acad Sci. 2009 Feb;1155:121-31
pubmed: 19250199
Dis Markers. 2019 Dec 1;2019:2814058
pubmed: 31871500
Cancer Lett. 2020 Feb 28;471:103-115
pubmed: 31838084
Epigenetics. 2008 Mar-Apr;3(2):59-63
pubmed: 18398311
Cell Signal. 2010 May;22(5):717-27
pubmed: 20006983
Mol Cell Biol. 2010 Sep;30(17):4267-79
pubmed: 20606007
Mol Cell Biol. 1992 May;12(5):2418-23
pubmed: 1373817
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3522-7
pubmed: 20133717
Clin Exp Metastasis. 2016 Apr;33(4):309-23
pubmed: 26862065
Front Cell Dev Biol. 2017 May 26;5:59
pubmed: 28603713
Breast Cancer Res. 2009;11(3):R32
pubmed: 19473496
Oncotarget. 2013 Nov;4(11):2144-53
pubmed: 24240169
Oncotarget. 2018 Nov 2;9(86):35639-35654
pubmed: 30479694
J Biol. 2005;4(1):2
pubmed: 15720723
EMBO Rep. 2021 Jun 4;22(6):e50600
pubmed: 33860601
Cell Rep. 2017 Mar 7;18(10):2359-2372
pubmed: 28273452
PLoS Genet. 2014 Sep 04;10(9):e1004610
pubmed: 25188404
Nature. 2002 Sep 26;419(6905):407-11
pubmed: 12353038
Proc Natl Acad Sci U S A. 2010 May 18;107(20):9216-21
pubmed: 20439735
J Cell Biol. 2008 Mar 24;180(6):1087-100
pubmed: 18347071
Cell Signal. 2018 Jul;47:52-64
pubmed: 29559363
Oncogene. 2015 Jan 8;34(2):188-98
pubmed: 24362520
Immunity. 2008 Dec 19;29(6):876-87
pubmed: 19062319
J Immunol. 2007 Oct 1;179(7):4405-14
pubmed: 17878336
NPJ Precis Oncol. 2020 Feb 12;4:2
pubmed: 32128448
Br J Haematol. 2008 Feb;140(4):394-401
pubmed: 18217891
Curr Opin Cell Biol. 2018 Apr;51:42-49
pubmed: 29153704
Cancer Cell. 2020 Apr 13;37(4):599-617.e7
pubmed: 32243837
Cytokine Growth Factor Rev. 2013 Apr;24(2):123-31
pubmed: 23102646
Immunol Lett. 2006 Jan 15;102(1):1-9
pubmed: 16140393
Nat Commun. 2017 Apr 25;8:15146
pubmed: 28440295
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W202-8
pubmed: 19458158

Auteurs

Isabel Castro-Piedras (I)

Immunology and Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, TX, USA.

Monica Sharma (M)

Immunology and Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, TX, USA.

Jennifer Brelsfoard (J)

Immunology and Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX, USA.

David Vartak (D)

Immunology and Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, TX, USA.

Edgar G Martinez (EG)

Immunology and Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, TX, USA.

Cristian Rivera (C)

Immunology and Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, TX, USA.

Deborah Molehin (D)

Immunology and Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, TX, USA.

Robert K Bright (RK)

Immunology and Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, TX, USA.

Mohamed Fokar (M)

Center for Biotechnology and Genomics, Texas Tech University, Lubbock, TX, USA.

Josee Guindon (J)

Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Center of Excellence for Translational Neuroscience and Therapeutics, Texas Tech University Health Sciences Center, Lubbock, TX, USA.

Kevin Pruitt (K)

Immunology and Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH